- Home
- KNTK vs ACLX Comparison
KNTK vs ACLX Comparison
Compare KNTK & ACLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNTK
- ACLX
- Stock Information
- Founded
- KNTK 2017
- ACLX 2015
- Country
- KNTK United States
- ACLX United States
- Employees
- KNTK N/A
- ACLX N/A
- Industry
- KNTK Natural Gas Distribution
- ACLX Biotechnology: Pharmaceutical Preparations
- Sector
- KNTK Utilities
- ACLX Health Care
- Exchange
- KNTK Nasdaq
- ACLX Nasdaq
- Market Cap
- KNTK 3.7B
- ACLX 3.6B
- IPO Year
- KNTK N/A
- ACLX 2022
- Fundamental
- Price
- KNTK $59.04
- ACLX $63.75
- Analyst Decision
- KNTK Buy
- ACLX Strong Buy
- Analyst Count
- KNTK 9
- ACLX 14
- Target Price
- KNTK $58.00
- ACLX $107.67
- AVG Volume (30 Days)
- KNTK 667.2K
- ACLX 532.8K
- Earning Date
- KNTK 02-26-2025
- ACLX 02-26-2025
- Dividend Yield
- KNTK 5.32%
- ACLX N/A
- EPS Growth
- KNTK 221.62
- ACLX N/A
- EPS
- KNTK 2.62
- ACLX N/A
- Revenue
- KNTK $1,446,081,000.00
- ACLX $155,818,000.00
- Revenue This Year
- KNTK $11.83
- ACLX $12.58
- Revenue Next Year
- KNTK $33.67
- ACLX N/A
- P/E Ratio
- KNTK $22.39
- ACLX N/A
- Revenue Growth
- KNTK 20.20
- ACLX 230.33
- 52 Week Low
- KNTK $33.10
- ACLX $47.88
- 52 Week High
- KNTK $67.60
- ACLX $107.37
- Technical
- Relative Strength Index (RSI)
- KNTK 38.26
- ACLX 41.49
- Support Level
- KNTK $60.00
- ACLX $62.38
- Resistance Level
- KNTK $64.48
- ACLX $67.00
- Average True Range (ATR)
- KNTK 1.84
- ACLX 2.82
- MACD
- KNTK -0.68
- ACLX 0.32
- Stochastic Oscillator
- KNTK 10.52
- ACLX 28.44
About KNTK Kinetik Holdings Inc.
Kinetik is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. It operates exclusively in Texas, serving the Permian Basin and connecting fields with market hubs and other large pipelines. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines that transport molecules to the Gulf Coast enabling it to obtain exposure to export markets and international demand.
About ACLX Arcellx Inc.
Arcellx Inc is a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases.